Interestingly, CD70 expression was found to be even higher in metastatic lung carcinoma, pancreatic carcinoma and osteosarcoma, suggesting the importance of CD70 in the progression of the disease (Flieswasser et al. 2019). Here, CD70 is linked to exocrine pancreatic carcinoma.